Drug Shortage Report for GLYCOPYRROLATE INJECTION USP
| Report ID | 234808 |
| Drug Identification Number | 02473887 |
| Brand name | GLYCOPYRROLATE INJECTION USP |
| Common or Proper name | GLYCOPYRROLATE INJECTION USP |
| Company Name | STERIMAX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | GLYCOPYRROLATE |
| Strength(s) | 4MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 1 x 20 mL Vial |
| ATC code | A03AB |
| ATC description | DRUGS FOR FUNCTIONAL BOWEL DISORDERS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2024-08-16 |
| Actual start date | |
| Estimated end date | 2025-09-15 |
| Actual end date | 2025-09-15 |
| Shortage status | Resolved |
| Updated date | 2025-09-18 |
| Company comments | Contracted customers have coverage in place where possible. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.